{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:43:54Z","timestamp":1793263434224,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21EB021570"],"award-info":[{"award-number":["R21EB021570"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jconrel.2021.03.032","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T03:43:22Z","timestamp":1616816602000},"page":"176-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Self-assembled elastin-like polypeptide fusion protein coacervates as competitive inhibitors of advanced glycation end-products enhance diabetic wound healing"],"prefix":"10.1016","volume":"333","author":[{"given":"Hwan June","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneel","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle","family":"D'Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biraja","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry C.","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L.","family":"Yarmush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Berthiaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jconrel.2021.03.032_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/wound.2019.0946","article-title":"Human wounds and its burden: an updated compendium of estimates","volume":"8","author":"Sen","year":"2019","journal-title":"Adv. Wound Care (New Rochelle)."},{"issue":"1","key":"10.1016\/j.jconrel.2021.03.032_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jval.2017.07.007","article-title":"An economic evaluation of the impact, cost, and Medicare policy implications of chronic nonhealing wounds","volume":"21","author":"Nussbaum","year":"2018","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jconrel.2021.03.032_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.diabres.2004.09.004","article-title":"Advanced glycation endproducts--role in pathology of diabetic complications","volume":"67","author":"Ahmed","year":"2005","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"6","key":"10.1016\/j.jconrel.2021.03.032_bb0020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.jconrel.2021.03.032_bb0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jdermsci.2016.07.008","article-title":"High-glucose environment disturbs the physiologic functions of keratinocytes: focusing on diabetic wound healing","volume":"84","author":"Hu","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jconrel.2021.03.032_bb0030","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature."},{"issue":"15","key":"10.1016\/j.jconrel.2021.03.032_bb0035","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kB - a pivotal transcription factor in chronic inflammatory disease","volume":"336","author":"Barnes","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2021.03.032_bb0040","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Sig. Transduct. Target Ther."},{"key":"10.1016\/j.jconrel.2021.03.032_bb0045","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI118175","article-title":"Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice","volume":"96","author":"Schmidt","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"44","key":"10.1016\/j.jconrel.2021.03.032_bb0050","doi-asserted-by":"crossref","first-page":"31740","DOI":"10.1074\/jbc.274.44.31740","article-title":"Ne-(Carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression","volume":"274","author":"Kislinger","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2021.03.032_bb0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9440(10)61723-3","article-title":"Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice","volume":"159","author":"Goova","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.jconrel.2021.03.032_bb0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/wound.2015.0674","article-title":"Soluble receptor for advanced glycation end products improves stromal cell-derived Factor-1 activity in model diabetic environments","volume":"5","author":"Olekson","year":"2016","journal-title":"Adv. Wound Care (New Rochelle)."},{"issue":"9","key":"10.1016\/j.jconrel.2021.03.032_bb0065","first-page":"368","article-title":"RAGE: A new target for the prevention and treatment of the vascular and inflammatory complications of diabetes","volume":"11","author":"Schmidt","year":"2000","journal-title":"TEM."},{"issue":"17","key":"10.1016\/j.jconrel.2021.03.032_bb0070","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1021\/acs.jmedchem.7b00058","article-title":"Targeting the receptor for advanced glycation Endproducts (RAGE): A medicinal chemistry perspective","volume":"60","author":"Bongarzone","year":"2017","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.jconrel.2021.03.032_bb0075","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.str.2011.02.013","article-title":"Advanced glycation end product recognition by the receptor for AGEs","volume":"19","author":"Xue","year":"2011","journal-title":"Structure."},{"key":"10.1016\/j.jconrel.2021.03.032_bb0080","doi-asserted-by":"crossref","first-page":"12299","DOI":"10.1021\/bi800910v","article-title":"Solution structure of the variable-type domain of the receptor for advanced glycation end products: new insight into AGE-RAGE interaction","volume":"47","author":"Matsumoto","year":"2008","journal-title":"Biochemistry."},{"issue":"4","key":"10.1016\/j.jconrel.2021.03.032_bb0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/wrr.12717","article-title":"Metalloproteinases in chronic and acute wounds: A systematic review and meta-analysis","volume":"27","author":"Tardaguila-Garcia","year":"2019","journal-title":"Wound Repair Regen."},{"issue":"3","key":"10.1016\/j.jconrel.2021.03.032_bb0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0022034509359125","article-title":"Factors affecting wound healing","volume":"89","author":"Guo","year":"2010","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jconrel.2021.03.032_bb0095","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0169-409X(02)00060-1","article-title":"Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery","volume":"54","author":"Chilkoti","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.03.032_bb0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2015.11.010","article-title":"Elastin-like polypeptides: therapeutic applications for an emerging class of nanomedicines","volume":"240","author":"Despanie","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.03.032_bb0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.biomaterials.2017.06.043","article-title":"Co-delivery of a growth factor and a tissue-protective molecule using elastin biopolymers accelerates wound healing in diabetic mice","volume":"141","author":"Devalliere","year":"2017","journal-title":"Biomaterials."},{"issue":"3","key":"10.1016\/j.jconrel.2021.03.032_bb0110","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1073\/pnas.1009881108","article-title":"Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds","volume":"108","author":"Koria","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.03.032_bb0115","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2016.04.020","article-title":"The development and characterization of SDF1alpha-elastin-like-peptide nanoparticles for wound healing","volume":"232","author":"Yeboah","year":"2016","journal-title":"J. Control. Release"},{"issue":"15","key":"10.1016\/j.jconrel.2021.03.032_bb0120","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.addr.2010.05.004","article-title":"Drug delivery to solid tumors by elastin-like polypeptides","volume":"62","author":"McDaniel","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.03.032_bb0125","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/15100","article-title":"Purification of recombinant proteins byfusion with thermally-responsive polypeptides","volume":"17","author":"Meyer","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.03.032_bb0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/B978-0-12-416039-2.00024-0","article-title":"Fusions of elastin-like polypeptides to pharmaceutical proteins","volume":"502","author":"Hassouneh","year":"2012","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.jconrel.2021.03.032_bb0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/wound.2016.0694","article-title":"Stromal cell-derived growth Factor-1 alpha-elastin like peptide fusion protein promotes cell migration and revascularization of experimental wounds in diabetic mice","volume":"6","author":"Yeboah","year":"2017","journal-title":"Adv. Wound Care (New Rochelle)."},{"issue":"10","key":"10.1016\/j.jconrel.2021.03.032_bb0140","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1089\/ars.2007.1999","article-title":"Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway","volume":"10","author":"Guo","year":"2008","journal-title":"Antioxid. Redox Signal."},{"issue":"10","key":"10.1016\/j.jconrel.2021.03.032_bb0145","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: property, design and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2021.03.032_bb0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.22267","article-title":"Acceptable levels of endotoxin in vaccine formulations during preclinical research","volume":"100","author":"Brito","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.jconrel.2021.03.032_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113840","article-title":"Residual endotoxin contaminations in recombinant proteins are sufficient to activate human CD1c+ dendritic cells","volume":"9","author":"Schwarz","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jconrel.2021.03.032_bb0160","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1021\/bm400167h","article-title":"Predicting transition temperatures of elastin-like polypeptide fusion proteins","volume":"14","author":"Christensen","year":"2013","journal-title":"Biomacromolecules."},{"issue":"2","key":"10.1016\/j.jconrel.2021.03.032_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020436","article-title":"Advanced glycation end products inhibit the proliferation of human umbilical vein endothelial cells by inhibiting Cathepsin D","volume":"18","author":"Li","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"40","key":"10.1016\/j.jconrel.2021.03.032_bb0170","doi-asserted-by":"crossref","first-page":"35061","DOI":"10.1074\/jbc.M111.261073","article-title":"Receptor for advanced glycation end products (RAGE) prevents endothelial cell membrane resealing and regulates F-actin remodeling in a beta-catenin-dependent manner","volume":"286","author":"Xiong","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.jconrel.2021.03.032_bb0175","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ajpath.2019.12.006","article-title":"Intercellular adhesion molecule 1 functions as an Efferocytosis receptor in inflammatory macrophages","volume":"190","author":"Wiesolek","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.jconrel.2021.03.032_bb0180","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/pro.2063","article-title":"Biodegradation of elastin-like polypeptide nanoparticles","volume":"21","author":"Shah","year":"2012","journal-title":"Protein Sci."},{"key":"10.1016\/j.jconrel.2021.03.032_bb0185","doi-asserted-by":"crossref","first-page":"2897656","DOI":"10.1155\/2016\/2897656","article-title":"The role of matrix metalloproteinases in diabetic wound healing in relation to Photobiomodulation","volume":"2016","author":"Ayuk","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"9","key":"10.1016\/j.jconrel.2021.03.032_bb0190","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1167\/iovs.15-16909","article-title":"The antioxidant N-acetylcysteine inhibits inflammatory and apoptotic processes in human conjunctival epithelial cells in a high-glucose environment","volume":"56","author":"Park","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2021.03.032_bb0195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/iwj.12557","article-title":"Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process","volume":"14","author":"Dunnill","year":"2017","journal-title":"Int. Wound J."},{"key":"10.1016\/j.jconrel.2021.03.032_bb0200","doi-asserted-by":"crossref","first-page":"1428537","DOI":"10.1155\/2017\/1428537","article-title":"Blocking AGE-RAGE signaling improved functional disorders of macrophages in diabetic wound","volume":"2017","author":"Wang","year":"2017","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.jconrel.2021.03.032_bb0205","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/labinvest.2016.113","article-title":"The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice","volume":"97","author":"Hansen","year":"2017","journal-title":"Lab. Investig."},{"issue":"12","key":"10.1016\/j.jconrel.2021.03.032_bb0210","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1089\/wound.2019.1098","article-title":"The evolution of animal models in wound healing research: 1993-2017","volume":"8","author":"Parnell","year":"2019","journal-title":"Adv. Wound Care (New Rochelle)."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921001437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921001437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:56:14Z","timestamp":1759161374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921001437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":42,"alternative-id":["S0168365921001437"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.03.032","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-assembled elastin-like polypeptide fusion protein coacervates as competitive inhibitors of advanced glycation end-products enhance diabetic wound healing","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}